Considering this observation, it can be proposed that IL-18, secreted as a result of NLRP3 inflammasome activation in the setting of lymphoma, can induce signaling pathways promoting lymphomagenesis via its interaction with the IL-18R on lymphoma B-cells. The gene discussed is NLRP3; the disease is lymphoma.